Rivka R. Colen
Rivka R. Colen
Adresse e-mail validée de mdanderson.org
Titre
Citée par
Citée par
Année
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas
Cancer Genome Atlas Research Network
New England Journal of Medicine 372 (26), 2481-2498, 2015
14852015
MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set
DA Gutman, LAD Cooper, SN Hwang, CA Holder, JJ Gao, TD Aurora, ...
Radiology 267 (2), 560-569, 2013
3082013
Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge
S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ...
arXiv preprint arXiv:1811.02629, 2018
2512018
Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme
PO Zinn, B Majadan, P Sathyan, SK Singh, S Majumder, FA Jolesz, ...
PloS one 6 (10), e25451, 2011
2502011
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ...
JCI insight 1 (2), 2016
1532016
Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor
R Jain, LM Poisson, D Gutman, L Scarpace, SN Hwang, CA Holder, ...
Radiology 272 (2), 484-493, 2014
1462014
Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers
R Jain, L Poisson, J Narang, D Gutman, L Scarpace, SN Hwang, C Holder, ...
Radiology 267 (1), 212-220, 2013
1262013
Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET–CT: comparison to histopathologic and …
JB Roedl, RR Colen, NS Holalkere, AJ Fischman, NC Choi, MA Blake
Radiotherapy and oncology 89 (3), 278-286, 2008
1162008
DNA repair and breast carcinoma susceptibility in women
JM Ramos, A Ruiz, R Colen, ID Lopez, L Grossman, JL Matta
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
882004
Safety, antitumor activity, and immune activation of pegylated recombinant human interleukin-10 (AM0010) in patients with advanced solid tumors
A Naing, KP Papadopoulos, KA Autio, PA Ott, MR Patel, DJ Wong, ...
Journal of Clinical Oncology 34 (29), 3562, 2016
832016
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients
M Nicolasjilwan, Y Hu, C Yan, D Meerzaman, CA Holder, D Gutman, ...
Journal of Neuroradiology 42 (4), 212-221, 2015
792015
A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature
PO Zinn, P Sathyan, B Mahajan, J Bruyere, M Hegi, S Majumder, ...
PloS one 7 (8), e41522, 2012
762012
Imaging of liver tumors using surface-enhanced Raman scattering nanoparticles
C Andreou, V Neuschmelting, DF Tschaharganeh, CH Huang, ...
ACS nano 10 (5), 5015-5026, 2016
742016
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival
P Wangaryattawanich, M Hatami, J Wang, G Thomas, A Flanders, J Kirby, ...
Neuro-oncology 17 (11), 1525-1537, 2015
672015
Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients
PO Zinn, RR Colen, EM Kasper, JK Burkhardt
International journal of oncology 42 (3), 929-934, 2013
672013
Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project
RR Colen, M Vangel, J Wang, DA Gutman, SN Hwang, M Wintermark, ...
BMC medical genomics 7 (1), 1-9, 2014
632014
NCI workshop report: clinical and computational requirements for correlating imaging phenotypes with genomics signatures
R Colen, I Foster, R Gatenby, ME Giger, R Gillies, D Gutman, M Heller, ...
Translational oncology 7 (5), 556-569, 2014
622014
Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus
JB Roedl, EF Halpern, RR Colen, DV Sahani, AJ Fischman, MA Blake
Molecular imaging and biology 11 (1), 54-60, 2009
612009
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
T Fujii, RR Colen, MA Bilen, KR Hess, J Hajjar, ME Suarez-Almazor, ...
Investigational new drugs 36 (4), 638-646, 2018
572018
Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death
RR Colen, J Wang, SK Singh, DA Gutman, PO Zinn
Radiology 275 (1), 215-227, 2015
572015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20